Bristol-Myers Squibb Co (NYSE:BMY)

58.59
Delayed Data
As of Nov 15
 +0.08 / +0.14%
Today’s Change
42.48
Today|||52-Week Range
59.18
+12.72%
Year-to-Date
Why Celgene's Latest FDA Approval Makes Bristol-Myers Squibb's Dividend Look Even Better
Nov 12 / MotleyFool.com - Paid Partner Content
How Sweet Were Nektar Therapeutics' Q3 Results?
Nov 07 / MotleyFool.com - Paid Partner Content
Why Bristol-Myers Squibb Stock Gained 13% in October
Nov 11 / MotleyFool.com - Paid Partner Content
Buy These 2 Stocks to Access China's Huge Healthcare Market
Nov 06 / MotleyFool.com - Paid Partner Content
Better Buy: Biogen vs. Celgene
Nov 10 / MotleyFool.com - Paid Partner Content
Should Merck Investors Worry About Bristol Myers' Lung Cancer Drug Results?
Nov 04 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close58.51
Today’s open58.54
Day’s range58.40 - 58.79
Volume9,725,844
Average volume (3 months)11,968,412
Market cap$95.5B
Data as of 6:30pm ET, 11/15/2019

Growth & Valuation

Earnings growth (last year)+393.92%
Earnings growth (this year)+9.09%
Earnings growth (next 5 years)+14.00%
Revenue growth (last year)+8.59%
P/E ratio16.9
Price/Sales3.77
Price/Book6.78

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk-0.61-1.05%
LLYEli Lilly and Co+1.80+1.62%
GSKGlaxoSmithKline+0.24+0.55%
CELGCelgene0.000.00%
Data as of 6:30pm ET, 11/15/2019

Financials

Next reporting dateJanuary 27, 2020
EPS forecast (this quarter)$0.92
Annual revenue (last year)$22.6B
Annual profit (last year)$4.9B
Net profit margin21.81%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
New York, New York

Forecasts